Economy minister Franz Fayot (LSAP) announced on Tuesday the imminent launch of a new financing tool for the health sector. The need for the sector to evolve, particularly against the backdrop of covid-19, has become urgent.
Although he hasn’t given details, Fayot took advantage of the annual Luxinnovation event to announce the imminent launch of this new financing tool, which will deal with public-private partnerships, in addition to research grants seeking takers at Luxembourg and European level and in addition to the Business Partnership Facility.
The conference was the place to tease this measure and remind people that Luxembourg has invested in the health sector for 10 years “as one of the priority sectors to diversify our economy,” according to Fayot.
Cancer Foundation, FNR Join Forces to Support Cancer Research chronicle.lu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chronicle.lu Daily Mail and Mail on Sunday newspapers.
Virus outpacing us Luxembourg health expert says by Yannick Lambert and Jeff Wiltzius 2 min. 15.02.2021 More rapid vaccination campaign would reduce the possibility of dangerous mutations The Luxembourg Institute of Health in Belval in the south of Luxembourg Photo: Guy Jallay
Countries should speed up their vaccination campaigns to avoid the coronavirus from changing into more dangerous forms, a Luxembourg health expert has said, as the Grand Duchy continues to lag behind other European countries in handing out the injections. The virus is currently outpacing us , Markus Ollert, a professor at the Luxembourg Institute of Health told the
Luxemburger Wort newspaper in an interview on Sunday.
RTL Today - Interview: Health officials concerned as mutations spread through Luxembourg today.rtl.lu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from today.rtl.lu Daily Mail and Mail on Sunday newspapers.
Global Proteomics Partnering Terms and Agreements Analysis Report 2020
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Proteomics Partnering Terms and Agreements 2010 to 2020 report provides an understanding and access to the Proteomics partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter Proteomics partnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors Proteomics technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.